ClinicalTrials.gg
RecruitingNCT07222046Updated Nov 16, 2026

Spinal Neurorehabilitation for Veterans With SCI

An interventional study of Neurophysiological and anatomical testing and Transcutaneous Spinal Stimulation in Spinal Cord Injuries, sponsored by VA Office of Research and Development. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 76 studies in Spinal Cord Injuries by VA Office of Research and Development — 17 open to participants now, 18 under way, 1 of them phase 3. Spinal Cord Injuries · VA Office of Research and Development.

Planned enrollment
16th of 69
40 · median 20
Started
2026
with 2 others
No phase
52 of 76
14 open now
Primary completion
2031-06
later than 15 of 17 live
Registered
72nd of 76
by date

Among the 76 studies in Spinal Cord Injuries by VA Office of Research and Development, this one is the 16th largest by planned enrollment of the 69 interventional ones that give a count, is one of 3 that started in 2026, is one of 52 with no phase, reaches primary completion later than 15 of the 17 other live ones, and was the 72nd registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

17 of the 76 studies in Spinal Cord Injuries by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:

11 more — sign in →

By country, each count listing its studies:

All 17 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 76 studies in Spinal Cord Injuries by VA Office of Research and Development, or all of them as a file.
02

Study summary

Chronic spinal cord injury (SCI) is a debilitating disorder in Veterans and the broader U.S. population that does not have a cure. Veterans with severe SCI demonstrate permanent loss of sensory and motor function below their injury resulting in decreased quality of life and independence. Recently, electrical spinal neuromodulation has emerged as a potential approach to restore voluntary motor function and locomotion in persons with chronic SCI. However, spinal neuromodulation has yet to translate to clinical use due to small sample sizes in research studies and a lack of information on which patients would benefit. Here, the investigators propose a novel approach to evaluate the priorities and barriers faced by Veterans with SCI to use spinal neuromodulation, understand the neural connections remaining in Veterans with severe SCI, and determine potential functional improvements using non-invasive spinal neuromodulation technology. This research represents the first step towards deploying techniques that could dramatically improve function and quality of life for Veterans with SCI.

Read the detailed description

The International Standards for Neurological Classification of SCI (ISNCSCI) exam is used to classify spinal cord injury (SCI) severity by determining the neurological injury level and functional completeness of SCI. However, anatomical, physiological, and functional studies have indicated that many participants with ISNCSCI-defined complete SCI retain connectivity through the SCI lesion. Due to the heterogeneity of SCI and the small-N in prior spinal neuromodulation studies, there are no diagnostic criteria to determine how SCI lesion profile affects the ability to restore sensorimotor function in the presence of spinal neuromodulation. Development of this knowledge is necessary to design precise spinal neuromodulation approaches and clinical trials that could restore function and improve quality of life for Veterans with chronic SCI. First, stakeholders will be engaged to define research priorities, meaningful outcomes, and barriers to participation in neuromodulation trials. The potential impact of neuromodulation and priorities of Veterans with SCI and their caretakers will be assessed across a nationwide survey. Spinal neuromodulation will be evaluated to determine how it could impact clinical practice and treatment of Veterans though survey of SCI physicians. Qualitative feedback will be obtained from Veterans with SCI regarding the expected and achieved outcomes with neuromodulation prior to and after undergoing functional neuromodulation experiments. Next, baseline anatomical and physiological connectivity measurements across ISNCSCI scores will be established. Veterans with SCI across INSCSCI grades will be recruited to determine residual spinal connectivity. Spinal cord anatomy will be assessed above, below, and at the SCI lesion through MR neuroimaging. Descending corticospinal connectivity will be evaluated with transcranial magnetic stimulation and ascending afferent signals will be evaluated through somatosensory evoked potentials. Finally, functional spinal connectivity during spinal neuromodulation will be evaluated. Volitional motor output will be assessed with and without non-invasive spinal neuromodulation. The sensory effects of spinal neuromodulation will be assessed through user reports of pain and somatosensation. Potential functional improvements in activities of daily living will be assessed with and without spinal neuromodulation.

03

Conditions studied

  • Spinal Cord Injuries

Keywords

  • Spinal neuromodulation
  • Transcutaneous stimulation
  • Spinal cord stimulation
  • Neuroanatomy
  • Neurorehabilitation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All participants must be able to independently read and understand study information materials necessary to ensure
  • All participants must have a chronic spinal cord injury occurring >1 year prior to study enrollment
  • Ability to follow simple commands in English

Exclusion criteria

Exclusion Criteria:

  • to the use of external magnetic or electrical stimulation (e.g., epilepsy, intracranial metal, implanted electrosensitive device, etc.)
  • Significant neurological comorbidities that may affect neurophysiological recordings
  • Functional disability prior to spinal cord injury
  • Visual or auditory disorders limiting ability to participate in study procedures
  • Pregnancy
  • Primary psychiatric disorders or dissociative mental symptoms that impair
  • Significant chronic pain that may preclude an magnetic resonance imaging (MRI) scan or performing neurorehabilitation exercises
  • Frequent and significant spasticity that may preclude an MRI scan or neurorehabilitation exercises
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Single-arm

    This is a single-arm study where all participants will undergo the same neurophysiological, imaging, and functional testing.

    Diagnostic Test: Neurophysiological and anatomical testing · Device: Transcutaneous Spinal Stimulation

Interventions

  • Diagnostic testNeurophysiological and anatomical testing

    All participants will undergo neurophysiological testing (transcranial magnetic stimulation and somatosensory evoked potentials) to determine residual neural connectivity. All participants will also undergo MRI of the spine to evaluate residual neural connections and changes above and below lesion. These values will be compared to the standard clinical evaluation of spinal cord injury (ISNCSCI exam).

  • DeviceTranscutaneous Spinal Stimulation

    All participants will undergo spinal neuromodulation through non-invasive transcutaneous spinal stimulation to determine the effects on voluntary motor function, sensation, and activities of daily living.

    Also known as: Digitimer DS7

06

What researchers measure

Primary outcomes

  1. Axial completeness of chronic spinal cord injury (SCI) based on spine magnetic resonance imaging (MRI)

    Spared region volume at the injury site as assessed by spine MRI will be compared with clinical SCI score as measured by the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) exam.

    Time frame: 5 years

  2. Sagittal completeness of chronic spinal cord injury (SCI) based on spine magnetic resonance imaging (MRI)

    Intramedullary lesion length will be measured via spine MRI and compared with clinical SCI score as measured by the ISCNSCI exam.

    Time frame: 5 years

  3. Presence of descending connections in chronic spinal cord injury based on transcranial magnetic stimulation

    The latency of transcranial magnetic stimulation pulses will be measured via electromyography and compared with clinical SCI score as measured by the ISCNSCI exam.

    Time frame: 5 years

  4. Presence of ascending connections in chronic spinal cord injury based on somatosensory evoked potentials.

    The latency of somatosensory evoked potential pulses will be measured via electromyography and compared with clinical SCI score as measured by the ISCNSCI exam.

    Time frame: 5 years

Secondary outcomes

  1. Research priorities of Veteran spinal cord injury stakeholders

    The research priorities of Veterans with chronic spinal cord injury will be obtained and compared with previously published results in the non-Veteran population.

    Time frame: 2 years

  2. Voluntary motor function in the presence of non-invasive stimulation

    Increases in electromyography will be assessed with and without the use of non-invasive transcutaneous spinal stimulation.

    Time frame: 5 years

  3. Sensory responses in the presence of non-invasive stimulation

    Participants will self-report any changes in sensation during the application of non-invasive transcutaneous spinal stimulation.

    Time frame: 5 years

07

Study locations

1 of 1 sites recruiting
  • VA Northern California Health Care System, Mather, CA
    Sacramento, California 95655-4200, United States
    Recruiting
    • Jonathan S Calvert, PhD MD · ContactJonathan.Calvert2@va.gov · (916) 843-7512
    • Jonathan S Calvert, PhD MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — The PI will share de-identified datasets and results collected through this proposal by depositing these data at the National Library of Medicine (NLM) PubMed Central website repository as this is a VA supported data repository. The raw and processed neurophysiological data will be shared with supplementary metadata that includes information about the study methodology used to collect the data, details about the code, and definitions of variables.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: The data will be posted following publication of the data in a scientific journal. It is anticipated that this project will produce approximately 1 publication per year after the second year, with the data published simultaneously. All of the data will be published at the conclusion of the study in five years. The deidentified data will be posted on publicly accessible servers and will be stored there permanently.

Access criteria: Deidentified data will be accessible by all who interested parties. Any further requests will be made and reviewed by the PI.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jun 2031, 57 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 57 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2025
First posted
Oct 29, 2025
StartActual
Aug 31, 2026
Primary completionEst.
Jun 30, 2031
CompletionEst.
Jun 30, 2031
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Minor edits
Nothing that changes what the study is or who can join. Edited: identifiers
1 update, last Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Minor edits only
    + 1 other change: identifiers

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07222046
Responsible party
Sponsor
First posted
Oct 29, 2025
Start date
Aug 31, 2026
Primary completion
Jun 30, 2031 (estimated)
Completion
Jun 30, 2031 (estimated)
Last update
Nov 16, 2026

Study contacts

Jonathan S Calvert, PhD MD
Contact
Jonathan.Calvert2@va.gov
(916) 843-7512
Jonathan S Calvert, PhD MD
principal investigator · VA Northern California Health Care System, Mather, CA

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion